V.TLT
|
With data that is way better than blockbuster Keytruda, you would think it is...
|
V.TLT
|
Jmm: I don't know about you, but I've invested in 4 other...
|
V.TLT
|
Like clockwork. Of late, seems to be toward the end of the day's...
|
V.TLT
|
On the US side, the big ask is sitting at 17.5 cents, daring you to buy. ...
|
V.TLT
|
Innovation = Science + Execution. VC backers in the US push the...
|
V.TLT
|
Legit: I sure hope you and Eoganacht are right. Would be best for us. I...
|
V.TLT
|
That's one way to read it, Eoganacht. The other is, like last time,...
|
V.TLT
|
About 25% came from insiders. While that's a good thing, I hope...
|
V.TLT
|
If not for the tinhats on this board we would all be bored. Budfoxx is...
|
V.TLT
|
Hit the "top floor" button on your mental elevator. The view...
|
V.TLT
|
Volume with a price drop is more indicative of something negative. I'm...
|
V.TLT
|
500K volume. Someone knew.
|
V.TLT
|
Must be another raise
|
V.TLT
|
Good question on the cash burn and runway. Don't know. But thank you for...
|
V.TLT
|
PDT as a treatment option must be a very low priority or not lucrative enough...
|
V.TLT
|
The kick in the g0nads will come when they file for the next PP. Probably in...
|
V.TLT
|
Overall, though BTD submission moved one year from their original estimate...
|
V.TLT
|
If we see more large buys towards close that pump the volume by AT LEAST...
|
V.TLT
|
@BK: aren't you glossing over very obvious facts? For one...
|
V.TLT
|
Great guess, socksnblonds . Yes, I think this is a different animal too...
|